Millennium Management’s Gossamer Bio GOSS Stock Holding History

Millennium Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,688	Closed	-$1.87M	–	7161
2022 Q1	$1.87M	Buy	+2,688	New	+$2.07M	﹤0.01%	3952
2020 Q4	–	Sell	-1,500	Closed	-$1.49M	–	5341
2020 Q3	$1.49M	Buy	1,500 +1,375	+1,100%	+$1.46M	﹤0.01%	2827
2020 Q2	$130K	Hold	125	–	–	﹤0.01%	3937
2020 Q1	$102K	Buy	+125	New	+$131K	﹤0.01%	3547

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.59B AUM 39.8% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Millennium Management's GOSS Position: Q2 2026 in Review

Millennium Management increased its Gossamer Bio (GOSS) stake by 1,182% in Q2 2026, buying an estimated $618K and bringing the position to 30,033 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #4941.

Millennium Management first reported a position in GOSS in Q1 2019 and has held it in 28 quarters since. The position peaked at $15.9M in Q3 2022. 167 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Millennium Management held 30,033 shares of Gossamer Bio worth $395K as of Q2 2026.
Millennium Management bought 27,690 Gossamer Bio shares in Q2 2026, an estimated $618K.
Gossamer Bio made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #4941 holding.
Millennium Management first reported a position in Gossamer Bio in Q1 2019 and has held it in 28 quarters since.
Millennium Management's Gossamer Bio position peaked at $15.9M in Q3 2022.
167 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.